PFD Closes $15.4M Medical Receivables Offering
News related to:PFD Capital Partners, Inc · 3 min read
IRVINE, NV, UNITED STATES, November 20, 2026 /CourierPR/ -- PFD Capital Partners, Inc., a specialty finance and investment management company operating at the intersection of structured finance and healthcare, has successfully closed a $15.4 million medical receivables offering. The funds were raised through subscriptions totaling $15,396,533 for PFDSelect Medical Receivables 1022, LLC. This achievement marks another milestone for PFD's medical receivables financing platform, which provides capital solutions to U.S. medical service providers treating patients injured in personal injury cases.
According to the company, the financing model enables medical providers to obtain capital against qualifying receivables, thereby avoiding the need to wait for payment following the resolution of personal injury claims. Through its affiliated companies, PFD supports the origination, financing, underwriting, servicing, and administration of medical receivable portfolios. As of March 31, 2026, PFD's reported cumulative financing activity included approximately $2.19 billion in billed medical receivables, of which approximately $1.57 billion remained outstanding. The platform had advanced approximately $389 million in capital to finance these receivables.
PFD Capital Partners, Inc., headquartered in Irvine, California, was founded in 2017. The company provides business-cycle capital solutions to medical service providers through a platform centered on personal injury medical receivables. Its services include underwriting, documentation, portfolio administration, servicing, and collections. The company's financing activities are conducted in reliance on Rule 506(c) of Regulation D under the Securities Act of 1933.
This announcement is provided for informational purposes concerning the closing of the offering and does not constitute an offer to sell or a solicitation of an offer to purchase securities. Historical financial and operating information does not guarantee future results. Medical receivables financing involves risks, including collection delays, reduced recoveries, illiquidity, and potential loss of invested capital. Reported billed receivable amounts do not represent fair market value or anticipated collection proceeds.
The platform's success in raising $15.4 million underscores the growing demand for capital solutions in the medical receivables sector. PFD's model is designed to provide much-needed liquidity to medical service providers, allowing them to focus on patient care without the burden of waiting for insurance claims to resolve. By advancing capital against receivables, PFD helps medical providers manage cash flow more effectively, ensuring they can continue to serve their patients efficiently.
As of March 31, 2026, PFD's reported cumulative financing activity included approximately $2.19 billion in billed medical receivables, of which approximately $1.57 billion remained outstanding. The platform had advanced approximately $389 million in capital to finance these receivables. These figures reflect historical financing activity and are separate from the proceeds of the Fund 1022 offering.
PFD Capital Partners, Inc., with its focus on providing business-cycle capital solutions, continues to play a crucial role in the healthcare industry. By offering a reliable and efficient financing model, PFD supports the financial stability of medical service providers, enabling them to deliver high-quality care to patients injured in personal injury cases. The company's commitment to innovation and support for the medical community is evident in its ongoing efforts to expand its platform and meet the growing needs of its clients.
This successful offering is a testament to PFD's ability to navigate the complexities of the medical receivables market and provide innovative solutions to its clients. As the company continues to grow and evolve, it remains dedicated to supporting the financial needs of medical service providers and enhancing the overall healthcare experience for patients.